Impact of fatty liver index and metabolic dysfunction-associated steatotic liver disease on the risk of benign prostatic hyperplasia in older male adults
Abstract Objective The objective of this study was to ascertain whether the fatty liver index (FLI) and metabolic dysfunction-associated steatotic liver disease (MASLD) are independent risk factors for benign prostatic hyperplasia (BPH) in older men, and to evaluate their clinical utility in risk st...
Saved in:
| Main Authors: | Fan Zhang, Wenjian Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Geriatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12877-025-06314-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influencing factors of postoperative urinary tract infection in benign prostatic hyperplasia patients complicated with non-alcoholic fatty liver disease
by: TIAN Mao, YE Chang
Published: (2024-11-01) -
Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01) -
Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01) -
THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01) -
Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)